BEDFORD, Mass. — Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quart…
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2020 results on Tuesday, May 12, 20
UBS Group AG trimmed its stake in shares of Novanta Inc (NASDAQ:NOVT) by 16.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission
Measuring Novanta Inc.'s (NasdaqGS:NOVT) track record of past performance is a valuable exercise for investors. It...
Ladenburg Thalmann Financial Services Inc. boosted its stake in Novanta Inc (NASDAQ:NOVT) by 6.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exc
Bank of New York Mellon Corp lowered its holdings in Novanta Inc (NASDAQ:NOVT) by 3.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 155,942 shares of the technology company’s
Novanta (NASDAQ:NOVT) has had a rough three months with its share price down 19%. However, a closer look at its sound...
AQR Capital Management LLC lowered its stake in shares of Novanta Inc (NASDAQ:NOVT) by 14.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Ex
Novanta Inc (NASDAQ:NOVT) has earned an average broker rating score of 3.00 (Hold) from the two brokers that cover the stock, Zacks Investment Research reports. Two equities research analysts have rat
Novanta Inc (NASDAQ:NOVT) – Equities research analysts at William Blair lowered their Q2 2020 earnings estimates for shares of Novanta in a research report issued to clients and investors on Thursda
Bank of America Corp DE boosted its stake in shares of Novanta Inc (NASDAQ:NOVT) by 5.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Com
Novanta Inc (NASDAQ:NOVT) – Equities researchers at William Blair reduced their Q1 2020 EPS estimates for Novanta in a research report issued on Thursday, April 2nd. William Blair analyst B. Drab no
Following through on its earlier statements that it planned to conduct another pivotal study, Novan (NASDAQ:NOVT) is sticking with SB206 despite two failed Phase 3 clinical trials in molluscum contagi
Novanta Inc (NASDAQ:NOVT) saw a significant growth in short interest during the month of March. As of March 13th, there was short interest totalling 514,300 shares, a growth of 5.5% from the February
Analysts forecast that Novanta Inc (NASDAQ:NOVT) will announce sales of $148.40 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Nova
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE